Open AccessDaily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response
Author(s) -
WonJung Koh,
Tae Sun Shim
Publication year - 2009
Publication title -
the journal of antimicrobial chemotherapy/journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp276
Subject(s) - linezolid , medicine , tuberculosis , extensively drug resistant tuberculosis , multiple drug resistance , drug resistance , drug , pharmacology , mycobacterium tuberculosis , microbiology and biotechnology , biology , bacteria , vancomycin , pathology , staphylococcus aureus , genetics